- Home
- PROK vs LNKB Comparison
PROK vs LNKB Comparison
Compare PROK & LNKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- LNKB
- Stock Information
- Founded
- PROK 2015
- LNKB 2018
- Country
- PROK United States
- LNKB United States
- Employees
- PROK N/A
- LNKB N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- LNKB
- Sector
- PROK Health Care
- LNKB
- Exchange
- PROK Nasdaq
- LNKB Nasdaq
- Market Cap
- PROK 237.4M
- LNKB 284.4M
- IPO Year
- PROK N/A
- LNKB N/A
- Fundamental
- Price
- PROK $1.54
- LNKB $7.49
- Analyst Decision
- PROK Buy
- LNKB Hold
- Analyst Count
- PROK 5
- LNKB 1
- Target Price
- PROK $4.50
- LNKB $7.50
- AVG Volume (30 Days)
- PROK 430.9K
- LNKB 43.8K
- Earning Date
- PROK 11-12-2024
- LNKB 01-27-2025
- Dividend Yield
- PROK N/A
- LNKB 3.88%
- EPS Growth
- PROK N/A
- LNKB 61.51
- EPS
- PROK N/A
- LNKB 0.17
- Revenue
- PROK N/A
- LNKB $86,138,000.00
- Revenue This Year
- PROK N/A
- LNKB N/A
- Revenue Next Year
- PROK N/A
- LNKB $9.49
- P/E Ratio
- PROK N/A
- LNKB $46.04
- Revenue Growth
- PROK N/A
- LNKB 151.51
- 52 Week Low
- PROK $1.18
- LNKB $5.86
- 52 Week High
- PROK $4.44
- LNKB $8.29
- Technical
- Relative Strength Index (RSI)
- PROK 37.52
- LNKB 49.88
- Support Level
- PROK $1.70
- LNKB $7.66
- Resistance Level
- PROK $2.03
- LNKB $7.89
- Average True Range (ATR)
- PROK 0.21
- LNKB 0.21
- MACD
- PROK -0.04
- LNKB -0.03
- Stochastic Oscillator
- PROK 0.74
- LNKB 10.91
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About LNKB LINKBANCORP Inc.
Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans.